Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 19 citing articles:

The Effects of Probiotics, Prebiotics and Synbiotics in Non-Alcoholic Fat Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review
Rodrigo Zamignan Carpi, Sandra Maria Barbalho, Kátia Portero Sloan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8805-8805
Open Access | Times Cited: 87
Metabolic Insights into Caffeine’s Anti-Adipogenic Effects: An Exploration through Intestinal Microbiota Modulation in Obesity
Isabela Monique Fortunato, Quélita Cristina Pereira, Fabrício de Sousa Oliveira, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1803-1803
Open Access | Times Cited: 9
Therapeutic efficacy of liraglutide versus metformin in modulating the gut microbiota for treating type 2 diabetes mellitus complicated with nonalcoholic fatty liver disease
Ying Xing, Zheng Rongjiong, Mayila Kahaer, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 20
Tactics with Prebiotics for the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease via the Improvement of Mitophagy
Ai Tsuji, Sayuri Yoshikawa, Yuka Ikeda, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5465-5465
Open Access | Times Cited: 16
The Role of Anthocyanins in Alleviating Intestinal Diseases: A Mini Review
Yang Liu, Iva Fernandes, Nuno Mateus, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 11, pp. 5491-5502
Closed Access | Times Cited: 7
Biomarkers for Health Functional Foods in Metabolic Dysfunction-Associated Steatotic Liver Disorder (MASLD) Prevention: An Integrative Analysis of Network Pharmacology, Gut Microbiota, and Multi-Omics
Heng Yuan, Eun-Soo Jung, Soo-Wan Chae, et al.
Nutrients (2024) Vol. 16, Iss. 18, pp. 3061-3061
Open Access | Times Cited: 7
Bacillus coagulans TCI711 Supplementation Improved Nonalcoholic Fatty Liver by Modulating Gut Microbiota: A Randomized, Placebo-Controlled, Clinical Trial
Rong‐Hong Hsieh, Yu‐Ju Chien, Wen-Yi Lan, et al.
Current Developments in Nutrition (2024) Vol. 8, Iss. 3, pp. 102083-102083
Open Access | Times Cited: 4
Machine learning uncovers manganese as a key nutrient associated with reduced risk of steatotic liver disease
Simon Schophaus, Kate Townsend Creasy, Paul‐Henry Koop, et al.
Liver International (2024) Vol. 44, Iss. 10, pp. 2807-2821
Open Access | Times Cited: 4
Effects of traditional Chinese medicine polysaccharides on chronic diseases by modulating gut microbiota: A review
Xinyu Li, Rixiang Zhu, Qian Liu, et al.
International Journal of Biological Macromolecules (2024), pp. 136691-136691
Closed Access | Times Cited: 4
JiGuCao capsule formula alleviates metabolic fatty liver disease by regulating the gut–liver axis and lipid metabolism
Wenying Qi, Xu Cao, Yue Chen, et al.
Phytomedicine (2025) Vol. 140, pp. 156559-156559
Open Access
Elevated red blood cell folate levels are associated with metabolic dysfunction-associated steatotic liver disease: results from NHANES 2017–2020
Xin Liao, Yu Song, Lin Wang, et al.
Frontiers in Physiology (2025) Vol. 16
Open Access
Microbiota Dysbiosis and Gut Barrier Dysfunction Associated with Non-Alcoholic Fatty Liver Disease Are Modulated by a Specific Metabolic Cofactors’ Combination
Sergio Quesada‐Vázquez, Caitlin Bone, Shikha Saha, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13675-13675
Open Access | Times Cited: 19
Case report of atypical undernutrition of hypoproteinemia type
Qun-Ru Wang, Jun Long, Chencheng Wang, et al.
Open Life Sciences (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 4
Interplay of gut microbiota, glucagon-like peptide receptor agonists, and nutrition: New frontiers in metabolic dysfunction-associated steatotic liver disease therapy
Merve Guney-Coskun, Metin Başaranoğlu
World Journal of Gastroenterology (2024) Vol. 30, Iss. 43, pp. 4682-4688
Closed Access | Times Cited: 1
Fagopyrum dibotrys extract alleviates hepatic steatosis and insulin resistance, and alters autophagy and gut microbiota diversity in mouse models of high-fat diet-induced non-alcoholic fatty liver disease
Dan Zhang, Yongfang Xu, Hang Chen, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 5
Simulate the Dynamic Interactions Across Nutritional Supplements, the Polybiome, and the Biochemical Approach Dependent on Patient-Derived Gastrointestinal Knowledge
Reyed M Reyed
Journal of Clinical Epidemiology & Toxicology (2023), pp. 1-15
Open Access | Times Cited: 2
Valorizing Agro‐Food Waste for Nutraceutical Development: Sustainable Approaches for Managing Metabolic Dysfunction‐Associated Steatotic Liver Disease and Related Co‐Morbidities
Laura Comi, Claudia Giglione, Fationa Tolaj, et al.
Food Frontiers (2024)
Open Access
Mechanism by which the inhibition of glycolysis by sodium butyrate alleviates liver injury in subchronic fluoride-exposed mice
Zimei Wu, C. A. P. F. Su, Zhiyu Ma, et al.
Research Square (Research Square) (2024)
Closed Access
Association between hepatocyte TM4SF5 expression and gut microbiome dysbiosis during non-alcoholic fatty liver disease development
Yangie Pinanga, Kyung‐hee Pyo, Eun‐Ae Shin, et al.
Life Sciences (2024), pp. 123164-123164
Closed Access
Page 1

Scroll to top